title: Misoprostol and the debate over off-label drug use.
authors.affiliation: University of Liverpool, Liverpool Women's Hospital, UK.
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Weeks
authors.forename: Christian
authors.initials: C
authors.lastname: Fiala
authors.forename: Peter
authors.initials: P
authors.lastname: Safar
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal; D000028:Abortion, Induced / Q000379:methods; D000349:Africa / Q000453:epidemiology; D000075202:Contraindications; D017277:Drug Approval; D004345:Drug Industry; D004348:Drug Labeling; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007751:Labor, Induced / Q000009:adverse effects*; D008428:Maternal Mortality; D016595:Misoprostol; D010120:Oxytocics; D011247:Pregnancy
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D010120:Oxytocics; D016595:Misoprostol